Rare and Orphan Diseases - Global Oncology Academy

Episodes 17-28 of 28

Understanding Anemia in Myelofibrosis: Multifactorial Origins and Management Strategies
Understanding Anemia in Myelofibrosis: Multifactorial Origins and Management Strategies
Project Oncology®
Understanding Anemia in Myelofibrosis: Multifactorial Origins and Management Strategies
- Charles Turck, PharmD, BCPS, BCCCP
- Prithviraj Bose, MD
A Patient-Centered Approach to Managing Anemia in Myelofibrosis
A Patient-Centered Approach to Managing Anemia in Myelofibrosis
Project Oncology®
A Patient-Centered Approach to Managing Anemia in Myelofibrosis
- Brian P. McDonough, MD, FAAFP
- John Mascarenhas, MD
- Lucia Masarova, MD
Exercise in Multiple Myeloma: Balancing Benefits and Safety
Exercise in Multiple Myeloma: Balancing Benefits and Safety
Project Oncology®
Exercise in Multiple Myeloma: Balancing Benefits and Safety
- Jens Hillengass, MD, PhD
Newly Diagnosed Multiple Myeloma: The Prognostic Significance of Lymphopenia
Newly Diagnosed Multiple Myeloma: The Prognostic Significance of Lymphopenia
Project Oncology®
Newly Diagnosed Multiple Myeloma: The Prognostic Significance of Lymphopenia
Diagnosing Castleman Disease: Key Considerations
Diagnosing Castleman Disease: Key Considerations
Project Oncology®
Diagnosing Castleman Disease: Key Considerations
- Mateo Bustamante
Improving Diagnosis of Castleman Disease: The Key Role of Stromal Cells
Improving Diagnosis of Castleman Disease: The Key Role of Stromal Cells
Project Oncology®
Improving Diagnosis of Castleman Disease: The Key Role of Stromal Cells
- Joshua Brandstadter, MD, PhD, MSc
Mastering the Complexity of AML Treatment: A Multidimensional Approach to Diagnosis, Therapy, and Side Effect Management
Mastering the Complexity of AML Treatment: A Multidimensional Approach to Diagnosis, Therapy, and Side Effect Management
CME/CE
Mastering the Complexity of AML Treatment: A Multidimensional Approach to Diagnosis, Therapy, and Side Effect Management
1.00 credit
- Amir T. Fathi, MD
- Courtney DiNardo, MD
- Brian A. Jonas, MD, PhD
1.00 credit
Optimizing the Screening of Precursor Diseases in Multiple Myeloma
Optimizing the Screening of Precursor Diseases in Multiple Myeloma
Project Oncology®
Optimizing the Screening of Precursor Diseases in Multiple Myeloma
- Betsy O'Donnell, MD
From MGUS to Multiple Myeloma: Understanding the Progression of Precursor Diseases
From MGUS to Multiple Myeloma: Understanding the Progression of Precursor Diseases
Project Oncology®
From MGUS to Multiple Myeloma: Understanding the Progression of Precursor Diseases
- Betsy O'Donnell, MD
Risk Stratification Models for Precursor Diseases in Multiple Myeloma
Risk Stratification Models for Precursor Diseases in Multiple Myeloma
Project Oncology®
Risk Stratification Models for Precursor Diseases in Multiple Myeloma
- Betsy O'Donnell, MD
Emerging Frontiers: CAR T-Cell Therapy for Solid Tumors in Thyroid Cancer
Emerging Frontiers: CAR T-Cell Therapy for Solid Tumors in Thyroid Cancer
Project Oncology®
Emerging Frontiers: CAR T-Cell Therapy for Solid Tumors in Thyroid Cancer
- Matt Birnholz, MD
- Saad Kenderian M.B, Ch.B
Genetic Research into Hypodiploid ALL
Genetic Research into Hypodiploid ALL
Focus on Cancer
Genetic Research into Hypodiploid ALL
- Bruce Bloom, DDS, JD
- Charles Mullighan, MBBS, MSc, MD

Previous
1
2
Next

2/2